title: Suspicion of interaction between maribavir and everolimus in a renal transplant recipient.
authors.affiliation: 1 Rennes University Hospital Department of Clinical and Biological Pharmacology and Pharmacovigilance Pharmacoepidemiology and Drug Information Center Rennes, France 2 Rennes 1 University Faculty of Medicine Laboratory of Experimental and Clinical Pharmacology Rennes, France 3 Inserm, CIC-P 1414 Clinical Investigation Center Rennes, France 4 Department of Infectious Diseases and Intensive Care Rennes University Hospital Rennes, France 5 Department of Nephrology Rennes University Hospital Rennes, France.
authors.forename: Marie Clémence
authors.initials: MC
authors.lastname: Verdier
authors.forename: Solène
authors.initials: S
authors.lastname: Patrat-Delon
authors.forename: Florian
authors.initials: F
authors.lastname: Lemaitre
authors.forename: Matthieu
authors.initials: M
authors.lastname: Revest
authors.forename: Joseph
authors.initials: J
authors.lastname: Rivalan
authors.forename: Christian
authors.initials: C
authors.lastname: Michelet
authors.forename: Eric
authors.initials: E
authors.lastname: Bellissant
mesh_terms: D000998:Antiviral Agents / Q000494:pharmacology*; D001562:Benzimidazoles / Q000494:pharmacology*; D004347:Drug Interactions; D000068338:Everolimus; D006801:Humans; D007166:Immunosuppressive Agents / Q000097:blood*; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D012263:Ribonucleosides / Q000494:pharmacology*; D020123:Sirolimus / Q000031:analogs & derivatives* / Q000097:blood; D004004:Dichlororibofuranosylbenzimidazole / Q000031:analogs & derivatives
chemical_list: D000998:Antiviral Agents; D001562:Benzimidazoles; D000068338:Everolimus; D007166:Immunosuppressive Agents; D012263:Ribonucleosides; D020123:Sirolimus; C400401:maribavir; D004004:Dichlororibofuranosylbenzimidazole